Your browser doesn't support javascript.
loading
A phase I study of high-dose rosuvastatin with standard dose erlotinib in patients with advanced solid malignancies.
Goss, Glenwood D; Jonker, Derek J; Laurie, Scott A; Weberpals, Johanne I; Oza, Amit M; Spaans, Johanna N; la Porte, Charles; Dimitroulakos, Jim.
Afiliação
  • Goss GD; Ottawa Hospital Research Institute, Centre for Cancer Therapeutics, Ottawa, Canada. ggoss@toh.on.ca.
  • Jonker DJ; The Ottawa Hospital Cancer Centre, Ottawa, Canada. ggoss@toh.on.ca.
  • Laurie SA; Department of Medicine, University of Ottawa, Ottawa, Canada. ggoss@toh.on.ca.
  • Weberpals JI; The Ottawa Hospital Cancer Centre, Ottawa, Canada.
  • Oza AM; Department of Medicine, University of Ottawa, Ottawa, Canada.
  • Spaans JN; The Ottawa Hospital Cancer Centre, Ottawa, Canada.
  • la Porte C; Department of Medicine, University of Ottawa, Ottawa, Canada.
  • Dimitroulakos J; Ottawa Hospital Research Institute, Centre for Cancer Therapeutics, Ottawa, Canada.
J Transl Med ; 14: 83, 2016 Mar 31.
Article em En | MEDLINE | ID: mdl-27036206
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Rosuvastatina Cálcica / Cloridrato de Erlotinib / Neoplasias Tipo de estudo: Prognostic_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Rosuvastatina Cálcica / Cloridrato de Erlotinib / Neoplasias Tipo de estudo: Prognostic_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2016 Tipo de documento: Article